The case for investing better in noncommunicable diseases - even in times of crisis
This is a new position paper highlighting three ways that countries and other stakeholders can invest better in NCDs to ensure equitable access to care and commodities, especially during this turbulent time in global health financing.
The position piece calls for stakeholders to focus on three priorities:
- Spend less on products that make us sick and spend more on systems to keep us healthy.
- Cut out inefficiencies across the supply chain to save lives, money, and time delivering NCD medicines to everyone who needs them.
- Track NCD spending from budget to real-world benefit to guarantee better decisions and better results.
Publication date: September 2025